• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Biotech

Wall Street Ponders Brexit’s Impact on Drug, Biotech Stocks

Steve Walker    June 29, 2016 July 8, 2016    No Comments on Wall Street Ponders Brexit’s Impact on Drug, Biotech Stocks

In a historic vote Thursday, Britain has decided to leave the European Union. And, swallowing hard, financial markets around the world are not taking the news very well. Stateside, the Dow… Read more »

Corporate    Aetna Inc., Alan Carr, Anthem Inc., AstraZeneca PLC, Biotech, Brexit, Celgene Corp., Dow Jones Industrial Average, Edison Investment, European Medicines Agency, European Union, Evercore ISI, Footsie, FTSE 100, Gilead Sciences Inc., GlaxoSmithKline PLC, HCA Holdings Inc., iShares Biotechnology Nasdaq Exchange Traded Fund, Jefferies, Maxim Jacobs, Needham, Novartis AG, Regeneron Pharmaceuticals Inc., Roche Holding AG, S&P 500, Tenet Healthcare Corp.

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Healthcare stocks roar back after slump, while biotech IPOs continue stampede into pipeline.
  • Smartphones are revolutionizing medicine as new apps proliferate. Then there’s the Facebook lesson for and against trusting that your data...
  • US citizen denied life-saving bone-marrow transplant from Iranian brother due to Trump travel ban. My very brief take.
  • Report says hardly any physicians read the medical journals for their particular field. Has era of “evidence-free medicine” finally arrived?
  • Tiny Scottish biotech TauRx lobs bomb into Alzheimer’s fracas with Phase 3 success.
  • CAR-T Therapy: Personalized medicine with the promise of a cure; payers will decide who gets it
  • Akebia shares soar on rich partnership with Otsuka; risky but rational gamble?
  • Although more expensive, study says teaching hospitals save more lives. My personal take.
  • Tiny Scottish biotech TauRx lobs bomb into Alzheimer’s fracas with Phase 3 success.
  • Breakthrough study linking menopause to increased risk of Alzheimer’s explains why far more women than men get the disease; what...
  • Alarming study concludes most new, pricey cancer drugs don’t work; why are we just hearing about this?
  • Rx Hall of Shame Update: Former Insys employee pleads guilty in US opioid drug probe; case against ex CEO Michael...
Copyright 2018
Ribosome by GalussoThemes.com
Powered by WordPress